After years on the sidelines while investors piled into the next big thing in AI or crypto, biotech is back in focus.

Who needs a Netflix subscription when you can pay a €50 per month for a chance at resurrection? Tomorrow Bio cryogenically ...

Current markets are fragile due to leverage, passive flows, and tech concentration. Learn why cash, caution, and active risk ...

Read here for Boston Scientific (BSX) stock's outlook ahead of Q3 earnings, assess valuation, margin pressures, and ...

Canary Capital’s Litecoin and Hedera ETFs near SEC approval despite shutdown, signaling a new wave of altcoin investment ...

NORTHAMPTON, MA / ACCESS Newswire / October 10, 2025 / Dow received distinction in the 2025 BIG Sustainability Awards, securing wins in four different categories as well as four Dow products being nam ...

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on ...

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the SPDR S&P Biotech ETF (XBI), a passively managed exchange traded fund launched on January 31 ...

Cabaletta Bio recently announced encouraging initial results from its RESET-PV trial, showing that rese-cel achieved complete B cell depletion and early clinical responses in pemphigus vulgaris ...

Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company advancing novel therapeutics for patients living with autoimmune, ...

Bayer agreed to acquire unlisted U.S. biotech firm Asklepios BioPharmaceutical Inc for as much as $4 billion in a bet on gene therapy with the help of modified viruses.

This week’s Five Stocks lineup features ASML’s bullish setup ahead of earnings, AEP’s safe-haven rally, MindMed’s breakout ...